VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
---|---|---|---|---|---|---|---|---|
TVIS10006502 | HBV | ENSG00000138039.15 | protein_coding | LHCGR | No | No | 3973 | P22888 |
TVIS30017091 | HIV | ENSG00000138039.15 | protein_coding | LHCGR | No | No | 3973 | P22888 |
TVIS20010110 | HPV | ENSG00000138039.15 | protein_coding | LHCGR | No | No | 3973 | P22888 |
TVIS20067968 | HPV | ENSG00000138039.15 | protein_coding | LHCGR | No | No | 3973 | P22888 |
TVIS20032707 | HPV | ENSG00000138039.15 | protein_coding | LHCGR | No | No | 3973 | P22888 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
Gene | LHCGR |
---|---|
DrugBank ID | DB00014 |
Drug Name | Goserelin |
Target ID | BE0000134 |
UniProt ID | P22888 |
Regulation Type | agonist |
PubMed IDs | 17139284; 17016423; 20053189 |
Citations | Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.@@Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.@@Kirby RS, Fitzpatrick JM, Clarke N: Abarelix and other gonadotrophin-releasing hormone antagonists in prostate cancer. BJU Int. 2009 Dec;104(11):1580-4. doi: 10.1111/j.1464-410X.2009.08924.x. |
Groups | Approved |
Direct Classification | Oligopeptides |
SMILES | CC(C)C[C@H](NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=CC=CC=C12)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NNC(N)=O |
Pathways | |
PharmGKB | PA164747674 |
ChEMBL | CHEMBL1201247 |